Biotechnology and Pharma Switzerland
Biotechnology and Pharma Germany
Biotechnology and Pharma Sweden
Biotechnology and Pharma UK
Biotechnology and Pharma
Ireland
Biotechnology and Pharma
France
Biotechnology and Pharma Italy
Biotechnology and Pharma Netherlands
Biotechnology and Pharma
Belgium
Biotechnology and Pharma Norway
Biotechnology and Pharma
D
enmark
Biotechnology and Pharma A
ustria
Biotechnology and Pharma
Greece
Biotechnology and Pharma Finland
Biotechnology and Pharma Spain
Biotechnology and Pharma Hungary
Biotechnology and Pharma Russia
Biotechnology and Pharma Czech Republic
Biotechnology and Pharma Estonia
Biotechnology and Pharma Poland
Biotechnology and Pharma Portugal
Biotechnology and Pharma
Slovakia
Biotechnology and Pharma Lithuania
Biotechnology and Pharma
Iceland
Biotechnology and Pharma Slovenia
Biotechnology and Pharma Bulgaria
Biotechnology and Pharma Romania
Biotechnologyand Pharma Macedonia
Biotechnology and Pharma Albania
Biotechnology and Pharma Luxembourg
Biotechnology and Pharma Serbia
Biotechnology and Pharma Cyprus
Biotechnology and Pharma Malta
Biotechnology and Pharma Belarus
Biotechnology and Pharma Croatia
Biotechnology and Pharma Ukraina
Biotechnology and Pharma Turkey
16.05.2008
Oxford Biomedica
Announces TROVAX
®
Phase II Trial Results in Renal Cancer to be Presented at ASCO
15.05.2008
Amgen
Highlights Data to Be Presented at ASCO
15.05.2008 Overview Provided for Studies to be Presented at the 2008 American Society of Clinical Oncology Annual Meeting; and Updated Timing Provided for Ongoing Study in Early-Stage Colon Cancer
15.05.2008
Genentech
Provides Update On Studies Of Investigational Biooncology Agents To Be Presented At The American Society Of Clinical Oncology Meeting
14.05.2008
Amarin
announces private placement for up to $60 million
14.05.2008
Merck
Cooperates With the University of Applied Science in Muenster
13.05.2008 Circadin launch rollout starts with the launch of the product in the important German market
13.05.2008
Active Biotech
advances ANYARA into Phase III clinical trial
12.05.2008
Bone Medical
further positive results from oral osteoporosis drug trial
09.05.2008
Oxford Biomedica
Annual General Meeting
09.05.2008
MediGene
Presents 3-Months Report 2008
09.05.2008 Actemra inhibits joint damage and improves physical function of patients with Rheumatoid Arthritis
08.05.2008
KeyNeurotek Pharmaceuticals AG
Reports Positive Phase I Data of Its Cannabinoid Receptor-Agonist
08.05.2008 Annual General Meeting of
Active Biotec
h AB
08.05.2008
Cytopia
announces novel anti-cancer drug development collaboration
08.05.2008 Zevalin Revenues Lead Cell Therapeutics, Inc.'s First Quarter 2008 Financial Results